Company Filing History:
Years Active: 2009
Title: Gary Musso: Innovator in Pharmaceutical Formulations
Introduction
Gary Musso is a notable inventor based in Parsippany, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of bivalirudin. With a total of 2 patents, his work focuses on improving the efficiency and purity of pharmaceutical products.
Latest Patents
Musso's latest patents revolve around pharmaceutical formulations of bivalirudin and the processes for creating these formulations. His innovations include pharmaceutical batches or formulations that contain bivalirudin as the active ingredient. These formulations are designed to maintain a maximum impurity level of Asp-bivalirudin that does not exceed about 0.6%. Additionally, the reconstitution time for these formulations is optimized to not exceed about 42 seconds. The preparation method involves dissolving bivalirudin in a solvent to create a first solution, followed by the efficient mixing of a pH-adjusting solution to form a second solution. The process concludes with the removal of the solvent and pH-adjusting solution solvent from the second solution.
Career Highlights
Throughout his career, Gary Musso has worked with reputable companies in the pharmaceutical industry, including The Medicines Company. His expertise in pharmaceutical formulations has positioned him as a valuable contributor to advancements in drug development.
Collaborations
Musso has collaborated with professionals in the field, including his coworker Gopal Krishna. These partnerships have facilitated the exchange of ideas and innovations, further enhancing the quality of pharmaceutical formulations.
Conclusion
Gary Musso's contributions to pharmaceutical formulations, particularly regarding bivalirudin, demonstrate his commitment to innovation in the field. His patents reflect a dedication to improving drug efficacy and safety, making a lasting impact on the pharmaceutical industry.